NM_000660.7:c.292G>A

Variant summary

Our verdict is Uncertain significance.
+3 Uncertain · Warm
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 3 classification points (ACMG Germline Pathogenicity v2019). PM1PM2BP4

The NM_000660.7(TGFB1):c.292G>A (p.Glu98Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.00000372 (AC=6) in the gnomAD database across 1,613,156 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.00000488. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (★). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.E98Q: Uncertain_significance (ClinVar VariationId 3020729, 1 star)

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000027 ( 0 hom. )

Consequence

TGFB1
NM_000660.7 missense

Scores

3
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.539

Publications

0 publications found
Variant links:
Genes affected
TGFB1 (HGNC:11766): (transforming growth factor beta 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016]
TGFB1 Gene-Disease associations (from GenCC):
  • Camurati-Engelmann disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Camurati-Engelmann disease type 1
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • inflammatory bowel disease, immunodeficiency, and encephalopathy
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • cystic fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
TMEM91 (HGNC:32393): (transmembrane protein 91) Predicted to act upstream of or within hematopoietic progenitor cell differentiation. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Jun 2026]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000660.7, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 3 points.

PM1Mutational hot spot or critical domain
UniProt domain with ≥4 pathogenic missense and OR ≥ 5 vs. background — hotspot (PM1); In-domain: 9 pathogenic, 3 benign rare missense variants (OR vs. background: 13.6).; ±8 AA neighbourhood: 0 pathogenic, 0 benign.
PM2Absent/extremely low in population databases
Very rare in gnomAD for AD/XL gene (popmax AF < threshold/10) — PM2; GnomAD popmax AF = 0.00000488 — very rare for AD+AR gene (threshold 0.0001) — PM2 moderate.
BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Supporting).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000660.7. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

TGFB1 NM_000660.7
MANE Select
HGVSc / HGVSpc.292G>Ap.Glu98Lys
Exon rankExon 1 of 7
missense
Prot: NP_000651.3UniProt: P01137A0A499FJK2

Ensembl Transcripts

TGFB1 ENST00000221930.6
TSL:1MANE Select
HGVSc / HGVSpc.292G>Ap.Glu98Lys
Exon rankExon 1 of 7
missense
Prot: ENSP00000221930.4UniProt: A0A499FJK2P01137
TMEM91 ENST00000539627.5
TSL:1
HGVSc / HGVSpc.-30+1551C>T
Exon rankIntron 1 of 2
intron
Prot: ENSP00000441900.1UniProt: F5GWC9
TMEM91 ENST00000966284.1
HGVSc / HGVSpc.-420C>T
Exon rankExon 1 of 4
5_prime_UTR_premature_start_codon_gain
Prot: ENSP00000636343.1UniProt: Q6ZNR0-1

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.0000131
AC:2
Hom:0
AN:152128
Cov:31
GnomAD2 exomes
AF: 0.00000405
AC:1
AN:247200
GnomAD4 exome
AF: 0.00000274
AC:4
Hom:0
AN:1461028
Cov:32
GnomAD4 genome
AF: 0.0000131
AC:2
Hom:0
AN:152128
Cov:31
TOPMed (Bravo)
AF: 0.0000151
AC:4
Hom:0
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.0000469
AC:1
Hom:0
AN:21310
Showing 6 sources

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not provided (1)

Computational Scores

AlphaGenome AVI
Pathogenic22
AlphaMissense
Benign0.13
BayesDel_addAF
Benign-0.053T
BayesDel_noAF
Benign-0.31
CADD
Benign21
DANN
Uncertain0.99
Eigen
Benign-0.68
Eigen_PC
Benign-0.71
FATHMM_MKL
Benign0.30N
FuncVEP CTI
Benign0.024
GPN-Star LLR
N/A-7.7
GPN-Star score
N/A7.7
LIST_S2
Uncertain0.90D
M_CAP
Benign0.046D
MetaRNN
Benign0.11T
MetaSVM
Benign-0.97T
Mutation Taster
N/A89/11polymorphism
PhyloP100
Benign0.54
popEVE
Benign-3.2
PrimateAI
Uncertain0.68T
PromoterAI
N/A0.040Neutral
PROVEAN
Benign-0.94N
RBP_binding_hub_radar
N/A0.0
RBP_regulation_power_radar
N/A1.1
REVEL
Benign0.18
Sift
Benign0.099T
Sift4G
Benign0.30T
VESM-3B
Benign-7.5
Showing 28 of 28 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.